Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-15 Sale | 2022-03-17 5:58 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 11,469 | $7.6337 | $87,551 | 1,253,141 (Indirect Direct) | View |
| 2021-03-15 Sale | 2021-03-17 5:00 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 8,053 | $38.23 | $307,889 | 1,223,826 (Indirect Direct) | View |
| 2021-01-14 Sale | 2021-01-19 4:31 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 30,000 | $31.52 | $945,469 | 1,231,511 (Indirect Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:36 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 15,000 | $32.88 | $493,146 | 1,261,511 (Indirect Direct) | View |
| 2020-10-15 Sale | 2020-10-16 6:55 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 15,000 | $40.49 | $607,392 | 1,276,511 (Indirect Direct) | View |
| 2020-09-21 Sale | 2020-09-22 4:48 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 15,000 | $35.3 | $529,545 | 1,291,741 (Indirect Direct) | View |
| 2020-03-16 Sale | 2020-03-18 4:32 pm | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 5,450 | $19.73 | $107,508 | 1,275,501 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-08 Option Award | 2023-06-12 4:14 pm | N/A 2033-06-07 | Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director | 23,600 | $0 | 39,651 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:09 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 92,958 | $0 | 150,000 (Direct) | View |
| 2023-03-22 Option Award | 2023-03-24 8:17 pm | N/A 2033-03-22 | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 990,832 | $0 | 2,447,772 (Direct) | View |
| 2023-03-14 Tax Withholding | 2023-03-16 5:08 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 35,879 | $5.47 | 1,456,940 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:33 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 57,042 | $0 | 57,042 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:04 pm | N/A 2032-06-15 | Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director | 23,600 | $0 | 34,451 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:41 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 91,235 | $0 | 150,000 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 5:49 pm | N/A 2032-03-23 | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 605,947 | $0 | 1,859,088 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 58,765 | $0 | 58,765 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-24 5:17 pm | N/A 2031-06-21 | Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director | 16,276 | $0 | 23,510 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 08:00 am | N/A 2030-03-18 | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 14,897 | $0 | 1,358,292 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 08:00 am | N/A N/A | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 14,897 | $18.22 | 1,358,292 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 4:51 pm | N/A 2031-03-26 | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 117,231 | $0 | 1,341,057 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 4:10 pm | 2021-04-07 2031-01-07 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 3:33 pm | N/A 2030-06-16 | Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director | 32,552 | $0 | 32,552 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-09 4:37 pm | 2018-12-03 2023-12-03 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 32,500 | $6 | 100,000 (Direct) | View |
| 2020-04-09 Exercise | 2020-04-09 4:37 pm | 2019-05-14 2024-05-14 | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 12,500 | $9 | 100,000 (Direct) | View |
| 2020-03-18 Option Award | 2020-03-20 4:36 pm | N/A 2030-03-17 | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 140,400 | $0 | 1,415,901 (Direct) | View |
| 2020-02-20 Other | 2020-02-24 5:14 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer | 237,155 | $25.3 | 1,517,157 (Indirect) | View |
Ownership | 2019-12-23 5:02 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director | 0 | $0 | 300,000 (Direct) | View |